chr16-54284769-C-A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_024336.3(IRX3):c.1112G>T(p.Gly371Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000089 in 1,460,584 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024336.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IRX3 | NM_024336.3 | c.1112G>T | p.Gly371Val | missense_variant | 2/4 | ENST00000329734.4 | NP_077312.2 | |
IRX3 | XM_005256139.4 | c.1112G>T | p.Gly371Val | missense_variant | 2/4 | XP_005256196.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRX3 | ENST00000329734.4 | c.1112G>T | p.Gly371Val | missense_variant | 2/4 | 1 | NM_024336.3 | ENSP00000331608.3 | ||
IRX3 | ENST00000558054.1 | c.73-457G>T | intron_variant | 2 | ENSP00000463991.1 | |||||
IRX3 | ENST00000558180.2 | n.891G>T | non_coding_transcript_exon_variant | 2/2 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152058Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000841 AC: 11AN: 1308416Hom.: 0 Cov.: 39 AF XY: 0.0000125 AC XY: 8AN XY: 642382
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74392
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2021 | The c.1112G>T (p.G371V) alteration is located in exon 2 (coding exon 2) of the IRX3 gene. This alteration results from a G to T substitution at nucleotide position 1112, causing the glycine (G) at amino acid position 371 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at